Search Results
Abstracts
Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers
S. Marot
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Prevalence and evolution of transmitted HIV drug resistance in Belgium between 2013 and 2019
V. Mortier
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Slidesets
Dose Individualization Potential for Checkpoint Inhibitors - Stijn Koolen, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Critical assessment of the global epidemiology of HCV- Peter Ferenci, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Health behavior modifiers- what works in adolescents- Audrey Pettifor
Presented at:
International Workshop on HIV & Adolescence 2017
Slidesets
O_11: HIV-1-infected Males and Females under Less-Drug Regimens Achieve Antiretroviral Levels above the Inhibitory Concentration in the Genital Tract.- Sandrine Lefeuvre
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Abstracts
Immunological Age Prediction in HIV-Infected, ART-Treated Individuals
Presented at:
International Workshop on HIV & Aging 2020
Slidesets
Resistance Considerations When Choosing Optimal Treatment Regimen - Laura Waters, MD, FRCP
Presented at:
GCC HIV Clinical Forum 2022
Slidesets
TAF – The latest update, which questions remain to be answered?- Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2017